UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 28, 2019 (October 22, 2019)

GALILEO ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

1049 Park Ave. 14A
New York, NY 10028
(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (347) 517-1041

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

On October 22, 2019, Galileo Acquisition Corp. (the “Company”) consummated its initial public offering (“IPO”) of 13,800,000 units (the “Units”), including 1,800,000 Units (the “Over-Allotment Units”) issued upon the exercise of the underwriters’ over-allotment option in full. Each Unit consists of one ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”) and one redeemable warrant of the Company (“Warrant”), with each Warrant entitling the holder thereof to purchase one Ordinary Share for $11.50. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $138,000,000. 

On October 22, 2019, simultaneously with the consummation of the IPO, the Company completed the private sale (the “Private Placement”) of an aggregate of 4,110,000 warrants (the “Private Placement Warrants”), 3,562,000 of which were issued to Galileo Founders Holdings, L.P. (the “Sponsor”) and 548,000 of which were issued to EarlyBirdCapital, Inc. (“EBC”) generating aggregate gross proceeds to the Company of $4,110,000.

A total of $138,000,000, comprised of the net proceeds from the IPO, sale of the Over-Allotment Units and the proceeds of the sale of the Private Placement Warrants were placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee on October 22, 2019.

An audited balance sheet as of October 22, 2019 reflecting receipt of the proceeds upon consummation of the IPO, the Over-allotment Units and the Private Placement, has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.